Morningstar

Morningstar, Inc.

Equity Bottom-Up

Varian Medical Systems' second-quarter results were slightly ahead of our forecast on the top line and orders growth. We’re maintaining our fair value estimate for now as the revenue and order outperformance was largely offset by the increase in reinvestments, proton-related expenses, and tariffs. Our wide moat rating is intact
The firm delivered strong results in all of its major geographies. Orders in North America continue to impress; the United States saw 12% growth fueled by several large…

United States

Varian Medical Systems, Inc.  designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00